Kadcyla Powder for Concentrate for Solution for Infusion 160 mg
Kadcyla (trastuzumab) is a HER2/neu receptor antagonist used to treat HER2-overexpressing breast cancer and metastatic gastric or gastroesophageal junction adenocarcinoma.
What it is
Kadcyla (trastuzumab) is a HER2/neu receptor antagonist, a type of targeted therapy that blocks the HER2 protein on cancer cells.
What it's used for
It is used in adults for the treatment of HER2-overexpressing breast cancer (adjuvant and metastatic) and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Patients are selected based on an FDA-authorized companion diagnostic test.
Common side effects
The most common side effects include headache, diarrhea, nausea, and chills. More serious side effects such as heart problems, infusion reactions, and lung toxicity can also occur.
Important cautions
Kadcyla can cause cardiomyopathy (heart muscle disease), infusion reactions, embryo-fetal toxicity, pulmonary toxicity, and worsening of chemotherapy-induced neutropenia. It has no contraindications listed. Your doctor will monitor your heart function and overall health during treatment.
Frequently asked questions
What is Kadcyla used for?
Kadcyla is used to treat HER2-overexpressing breast cancer and HER2-overexpressing metastatic stomach cancer or cancer of the gastroesophageal junction.
What are the side effects of Kadcyla?
Common side effects include headache, diarrhea, nausea, and chills. Serious side effects may include heart problems, allergic reactions during infusion, and lung issues.
Can I buy Kadcyla without a prescription in Nigeria?
According to the product information, Kadcyla is available without a prescription in Nigeria.
How is Kadcyla taken?
Kadcyla is given as an intravenous (IV) infusion into a vein. It must be administered by a healthcare professional and not as a quick injection.
This information is for general guidance only and is not medical advice. Please consult your physician or pharmacist before using any medication.
